abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeblueskyburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfilterflaggenderglobeglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalitywebwhatsappxIcons / Social / YouTube
Article

20 May 2007

Author:
Agence France Presse

Nigerian state sues Pfizer over 'deformity' drug

Nigeria's largest state has sued US drug firm Pfizer for allegedly using 200 children as "guinea pigs" for a drug test in 1996 that led to multiple deaths and deformities, officials said Sunday...The state accuses Pfizer of "secretly using children as guinea pigs to test a drug under the guise of humanitarian gesture"...Pfizer was alleged to have administered an untested drug called Trovan Floxacin without authorisation on almost 200 children infected with meningitis in the state. Eleven of the children reportedly died, while the remaining 181 were said to have suffered from deafness, paralysis, brain damage and blindness.

Part of the following timelines

Nigeria’s Kano state sues Pfizer over alleged use of children for drug test that led to deaths and deformities

Pfizer lawsuit (re administration of experimental drug in Nigeria, filed in Nigeria)

Privacy information

This site uses cookies and other web storage technologies. You can set your privacy choices below. Changes will take effect immediately.

For more information on our use of web storage, please refer to our Data Usage and Cookies Policy

Strictly necessary storage

ON
OFF

Necessary storage enables core site functionality. This site cannot function without it, so it can only be disabled by changing settings in your browser.

Analytics cookie

ON
OFF

When you access our website we use Google Analytics to collect information on your visit. Accepting this cookie will allow us to understand more details about your journey, and improve how we surface information. All analytics information is anonymous and we do not use it to identify you. Google provides a Google Analytics opt-out add on for all popular browsers.

Promotional cookies

ON
OFF

We share news and updates on business and human rights through third party platforms, including social media and search engines. These cookies help us to understand the performance of these promotions.

Your privacy choices for this site

This site uses cookies and other web storage technologies to enhance your experience beyond necessary core functionality.